Description
Dinar (Ethylmethylhydroxypyridine Succinate) Solution for Injections 50 mg/ml – 2 ml Ampoules №10
Ingredients:
Each 2 ml ampoule contains 100 mg of ethylmethylhydroxypyridine succinate as the active ingredient.
Mechanism of Action:
Ethylmethylhydroxypyridine succinate acts as a neuroprotective agent by improving cerebral circulation and exerting antioxidant effects, thereby enhancing cognitive function and neurological outcomes.
Pharmacological Properties:
Dinar solution exerts its therapeutic effects through its ability to enhance cerebral blood flow, protect neurons from oxidative damage, and improve cognitive function in patients with cerebrovascular disorders.
Indications for Use:
Dinar solution is indicated for the treatment of cerebrovascular disorders, cognitive impairment, and neurological conditions associated with cerebral circulation insufficiency.
Contraindications:
Do not use Dinar solution in patients with hypersensitivity to ethylmethylhydroxypyridine succinate or any of the excipients present in the formulation.
Side Effects:
Common side effects may include gastrointestinal disturbances, allergic reactions, and rare cases of skin rashes. Monitor patients for any adverse reactions during treatment.
Usage Instructions:
The recommended dosage of Dinar solution should be determined by a healthcare professional and administered via intramuscular or intravenous injection. Adhere to the prescribed dosage and frequency of administration.
Benefits Compared to Analogues:
Dinar solution offers a unique combination of neuroprotective and antioxidant properties, making it effective in improving cognitive function and neurological outcomes in patients with cerebrovascular disorders compared to other treatment options.
Suitable Patient Groups:
Dinar solution is suitable for adult patients with cerebrovascular disorders, cognitive impairment, and neurological conditions associated with cerebral circulation insufficiency. Use in children, pregnant women, and elderly individuals should be based on healthcare provider recommendations.
Storage Conditions and Shelf Life:
Store Dinar solution in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.
Packaging Description:
Dinar solution is provided in 2 ml ampoules, each containing 50 mg/ml of ethylmethylhydroxypyridine succinate. Each package includes 10 ampoules for multiple doses.
Scientific Evidence:
Dinar (ethylmethylhydroxypyridine succinate) has shown promising results in improving cognitive function and neurological outcomes in patients with cerebrovascular disorders. Studies have demonstrated its neuroprotective and antioxidant properties, indicating its potential in managing cerebral circulation insufficiency.
Additional Information:
It is crucial to closely monitor patients for any adverse reactions or side effects while using Dinar solution. Consult a healthcare professional for more information on the benefits and appropriate use of Dinar in the treatment of cerebrovascular disorders.
